News Release
- What's News December 18, 2023 Submission of new drug application of amifampridine phosphate (3,4-diaminopyridine) for Lambert-Eaton myasthenic syndrome (LEMS) in Japan
- What's News July 24, 2023 Results of a Phase 3 study of Amifampridine phosphate (3,4-diaminopyridine) for Lambert-Eaton myasthenia syndrome (LEMS) in Japan
- What's News July 15, 2022 Acquisition of Marketing Licenses for Pharmaceuticals
About DyDo Pharma’s Businesses
Why We Entered the Pharmaceuticals Business
Supporting human health through the development of a variety of therapeutic drugs.
Business Model
Our operations are based on collaboration and alliance with partners operating in a wide range of fields.
Developed Items
Let’s look at what DyDo Pharma has to offer.